Healthcare

Fusion Biopsy Market to Grow Along with Rising Population During the Forecast Period – Vision Research Reports

Vision Research Report, Recently Announced New Report on “fusion biopsy market – Global Industry Analysis, Market Size, Share, Growth, Trends, Region Outlook, And Segment Forecasts, 2021 – 2030″.

Global “Fusion biopsy market” Report 2021 covering manufacturers, regions, segments, forecast to 2030 is that the recent research report with correct information and extremely authentic info. The report provides insights on market share, market size, rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors. The Fusion biopsy research report focuses on the competitive surroundings that has section on company profile covering product specifications, geographical coverage, recent developments, revenue analysis, and market shares. what is more, the report offers strategic recommendations so as to help the consumers to align business goals.

The Fusion biopsy market revenue share is set to grow at a yearly rate of 13.6% during 2021-2030, while its valuation is Projected to jump from $ 589.1 million in 2020 to $3.12 Bn in 2030.

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38468

Report Highlights

The transrectal segment dominated the market for fusion biopsy and accounted for the largest revenue share of 96.7% in 2020 because it was considered as the gold standard in performing prostate biopsy worldwide in the past decades. Most of the commercially available fusion biopsy was limited to the transrectal approach, contributing to its largest market share.

Transperineal fusion biopsy is an emerging trend and is expected to experience the fastest CAGR of 25.2% during the forecast period. Lower risk of infection and rectal bleeding in comparison to the traditional approach is expected to contribute towards the segment growth.

The hospitals segment dominated the market for fusion biopsy and held the largest revenue share of 71.0% in 2020 owing to their high purchasing power. The average unit price of a fusion biopsy system is expensive, making it unaffordable for private diagnostic centers.

The diagnostics centers segment is expected to grow at a significant rate in the market for fusion biopsy over the forecast period. Shorter wait times, cost efficiency, and a developing reimbursement paradigm are the factors expected to drive the growth of this segment.

The ambulatory care centers segment is expected to grow at the fastest rate of 22.6% during the forecast period. The rising prevalence of prostate cancer in rural areas having limited access to healthcare services is the factor expected to drive the growth of the segment.

North America dominated the market for fusion biopsy and accounted for the largest revenue share of 56.2% in 2020 and is expected to continue its dominance over the forecast period. The Asia Pacific is anticipated to register the fastest growth in the fusion biopsy market. The presence of key players, increase in the incidence of prostate cancer, and development of healthcare infrastructure are factors likely to propel market growth.

In Asia Pacific, the market for fusion biopsy is anticipated to witness a CAGR of 22.0% during the forecast period. The Asia Pacific exhibits a lucrative growth opportunity with the emerging economies at the forefront of development. The major factors driving the growth of the market include rising awareness of prostate cancer, increasing population base, and rising disposable income levels as well as high unmet needs of the patients in emerging countries such as India,

Global Fusion biopsy market report provides key statistics on the state of the trade and could be a valuable supply of steerage and direction for corporations and people curious about the market. The Fusion biopsy trade trends and promoting channels analysed. Fusion biopsy Market discovers numerous topics like regional market scope, product market numerous applications, market size consistent with specific product, sales and revenue by region, producing analysis, Industrial Chain, Market result Factors Analysis, market size forecast, and more. Finally, the practicableness of latest investment comes is evaluated and overall analysis conclusions offered.

Key Players

  • MedCom
  • ESAOTE SPA
  • KOELIS
  • Focal Healthcare
  • GeoScan Medical
  • UC-Care Medical Systems Ltd.

Market Segmentation

  • Biopsy Route
    • Transrectal
    • Transperineal
  • End-use
    • Hospitals
    • Diagnostic Centers
    • Ambulatory Care Centers
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Switzerland
      • Belgium
    • Asia Pacific
      • China
      • Japan
      • India
      • Thailand
      • South Korea
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Global Fusion biopsy Market: Drivers and Restrains

The analysis report has incorporated the analysis of various factors that augment the market’s growth. It constitutes trends, restraints, and drivers that remodel the market in either a positive or negative manner. This section additionally provides the scope of various segments and applications that may probably influence the market within the future. The elaborated info is predicated on current trends and historic milestones. This section additionally provides an analysis of the amount of production regarding the world market and regarding every kind from 2021-2030.

COVID-19 impact on the Fusion biopsy market

COVID-19 is associate communicable disease caused by the novel coronavirus. for the most part unknown before this happening across the world, COVID-19 has captive from a regional crisis to a worldwide pandemic in precisely a matter of a number of weeks. the world Health Organization (WHO) declared COVID-19 as an epidemic on March 11, 2021.

COVID-19 has compact most the industries across the world by disrupting provide chains and impeding numerous industrial operations. COVID-19-responsive measures undertaken by governments, like lockdown and social distancing, led to the closure of producing plants in the initial stage of the pandemic. With only a few industrial operations allowed, the demand for numerous input product within the industrial sector has declined considerably.

Key Highlights Involved in the Market Research Report: –

Fusion biopsy Market Study Coverage: It includes key market segments, key makers covered, the scope of product offered within the years thought of, world Fusion biopsy Market and study objectives. in addition, it touches the segmentation study provided within the report on the idea of the sort of product and applications.

Fusion biopsy Market executive Summary: This section emphasizes the key studies, market rate, competitive landscape, market drivers, trends, and problems additionally to the gross indicators.

Fusion biopsy Market Production by Region: The report delivers knowledge associated with import and export, revenue, production, and key players of all regional markets studied area unit coated during this section.

Fusion biopsy Market Profile of Manufacturers: Analysis of every market player profiled is elaborated during this section. This section conjointly provides SWOT analysis, products, production, value, capacity, and different very important factors of the individual player.

  • Statistical analysis touching on market size, sales volume, and overall business revenue.
  • Organized mentions of major market trends.
  • Growth opportunities.
  • Figures showcasing market rate.
  • Advantages and disadvantages of direct and indirect sales channels.
  • Insights concerning traders, distributors, and dealers present within the industry.

The report delivers a comprehensive study of all the segments and shares info concerning the leading regions within the market. This report additionally states import/export consumption, offer and demand Figures, cost, business share, policy, price, revenue, and gross margins.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Fusion Biopsy Market, By Biopsy Route

7.1.  Fusion Biopsy Market, by Biopsy Route, 2021-2030

7.1.1.    Transrectal

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Transperineal

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Fusion Biopsy Market, By End-use

8.1.  Fusion Biopsy Market, by End-use, 2021-2030

8.1.1.    Hospitals

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Diagnostic Centers

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Ambulatory Care Centers

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Fusion Biopsy Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.1.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.2.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.3.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.4.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.5.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Biopsy Route (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

Chapter 10.  Company Profiles

10.1.              MedCom

10.1.1.  Company Overview

10.1.2.  Biopsy Route Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              ESAOTE SPA

10.2.1.  Company Overview

10.2.2.  Biopsy Route Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              KOELIS

10.3.1.  Company Overview

10.3.2.  Biopsy Route Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Focal Healthcare

10.4.1.  Company Overview

10.4.2.  Biopsy Route Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              GeoScan Medical

10.5.1.  Company Overview

10.5.2.  Biopsy Route Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              UC-Care Medical Systems Ltd.

10.6.1.  Company Overview

10.6.2.  Biopsy Route Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38468

About Us: Vision Research Reports is unquestionably an expert in providing research reports on a diverse number of subjects including Alternative and Green Energy, Chemical, Energy, Glass, Machinery, Manufacturing, and Pharmaceuticals and Materials. We cater to distinguished MNCs, private equity firms, SMEs and Chinese companies pertaining to their market research data requirements.

We offer generic and amalgamated studies as well as customized studies to our clients based on their specific requirements. Our modus operandi constitutes of detailed and meticulous market surveys, company profiling, competitive landscaping and primary interviews.  Our prudent insights have been vital in the inception of many investment programs, new project development programs, startups and technology breakthroughs.

Contact Us:

Call: +1 9197 992 333

Vision Research Reports

Any Assistance, Email – sales@visionresearchreports.com

Nova

Recent Posts

Clinical Trial Biorepository & Archiving Solutions Market 2021 Future Development Status Recorded during 2030

Vision Research Report, Recently Announced New Report on "clinical trial biorepository & archiving solutions market …

3 years ago

Clinical Trial Kits Market Present Scenario and Growth Prospects 2021-2030

Vision Research Report, Recently Announced New Report on "clinical trial kits market - Global Industry…

3 years ago

Surfing Equipment Market Global Industry Analysis, Share, Statistics, Trends, Opportunities and Forecasts by 2030

Vision Research Report, Recently Announced New Report on "surfing equipment market - Global Industry Analysis,…

3 years ago

Flow Diverters Market Dynamics Forecast Analysis and Supply Demand By 2030

Vision Research Report, Recently Announced New Report on "Flow Diverters market - Global Industry Analysis,…

3 years ago

Polymerase Chain Reaction Market 2021 Future Development Status Recorded during 2030

Vision Research Report, Recently Announced New Report on "polymerase chain reaction market - Global Industry…

3 years ago

Neurovascular Catheters Market Present Scenario and Growth Prospects 2021-2030

Vision Research Report, Recently Announced New Report on "neurovascular catheters market - Global Industry Analysis,…

3 years ago